New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Repros Therapeutics (RPRX)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
0
0
1000
2000
1000
Cost of Revenue
-31.0K
0
0
0
0
Gross Profit
31.0K
0
1000
2000
1000
Research & Development
1.47M
2.18M
3.13M
6.57M
6.31M
SG&A
973K
922K
1.45M
1.48M
1.07M
Amortization & Deprec
31.0K
37.0K
0
39.0K
53.0K
Other Expenses
0
-37.0K
0
10.1M
-53.0K
Total Operating Expenses
2.47M
3.10M
4.58M
18.2M
7.38M
Operating Income
-2.44M
-3.10M
-4.58M
-18.2M
-7.37M
Other Income
0
0
0
0
0
EBIT
-2.44M
-3.10M
-4.58M
-18.2M
-7.37M
Minority Interest
0
0
0
0
0
Interest Expense
0
0
0
0
0
Income Before Taxes
-2.44M
-3.10M
-4.58M
-18.2M
-7.37M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-2.44M
-3.10M
-4.58M
-18.2M
-7.37M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-2.44M
-3.10M
-4.58M
-18.2M
-7.37M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-2.44M
-3.10M
-4.58M
-8.04M
-7.37M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour